Skip to main content
Premium Trial:

Request an Annual Quote

If Shareholders Approve, Hycor Merger with Stratagene to Close Soon After June 2

NEWS YORK, April 30 (GenomeWeb News) - Hycor Biomedical's merger with Stratagene is expected to close "soon after" June 2, when Hycor's shareholders will vote on the merger, the companies said today.


The merger, announced last July, is subject to approval from both Hycor and Stratagene stockholders, as well as certain other conditions.


The SEC declared effective a registration statement relating to Stratagene issuing common stock in connection with the merger, the companies said today.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.